Clinical utility of Cerebrospinal fluid Amyloid-? and tau measures in diagnosing mild cognitive impairment in early onset dementia (2022)
Attributed to:
Brain Iron Toxicity and Neurodegeneration - MRI study at 7T
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Parent Publication: Journal of Alzheimer's Disease